Status:
COMPLETED
Anaesthetic Management of Women With Heart Disease For Labor and Delivery
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Heart Diseases
Pregnancy
Eligibility:
FEMALE
Brief Summary
Heart disease among pregnant women is increasing in incidence. The cardiovascular changes associated with pregnancy may be particularly hazardous for both mother and fetus in a subset of these patient...
Detailed Description
Heart disease among pregnant women is increasing in incidence. The cardiovascular changes associated with pregnancy may be particularly hazardous for both mother and fetus in a subset of these patient...
Eligibility Criteria
Inclusion
- Pregnant women with congenital or acquired heart disease
- Pregnant women with arrhythmias are also included providing they had had symptomatic tachyarrhythmias or bradyarrhythmias requiring treatment
Exclusion
- Women with isolated mitral valve prolapse including those with mild to moderated mitral regurgitation
- Women referred for termination of pregnancy
Key Trial Info
Start Date :
November 1 2002
Trial Type :
OBSERVATIONAL
End Date :
June 1 2005
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00403871
Start Date
November 1 2002
End Date
June 1 2005
Last Update
March 2 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5
2
Univeristy Health Network
Toronto, Ontario, Canada, M5G 1Z5